These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 33708860)

  • 1. A nomogram for the predicting of survival in patients with esophageal squamous cell carcinoma undergoing definitive chemoradiotherapy.
    Wang P; Yang M; Wang X; Zhao Z; Li M; Yu J
    Ann Transl Med; 2021 Feb; 9(3):233. PubMed ID: 33708860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting Severe Radiation Esophagitis in Patients With Locally Advanced Esophageal Squamous Cell Carcinoma Receiving Definitive Chemoradiotherapy: Construction and Validation of a Model Based in the Clinical and Dosimetric Parameters as Well as Inflammatory Indexes.
    Yu Y; Zheng H; Liu L; Li H; Zheng Q; Wang Z; Wu Y; Li J
    Front Oncol; 2021; 11():687035. PubMed ID: 34249736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Prognostic Significance of Nomogram-Based Pretreatment Inflammatory Indicators in Patients With Esophageal Squamous Cell Carcinoma Receiving Intensity-Modulated Radiotherapy.
    Xu Z; Ke H; Zheng B; Lin C; Zhang Y; Wang L; Lin Y; Ye Y; Cai L; You M; Chen J; Xu Y
    Cancer Control; 2023; 30():10732748231185025. PubMed ID: 37339928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A nomogram to predict short-term outcome of radiotherapy or chemoradiotherapy based on pre/post-treatment inflammatory biomarkers and their dynamic changes in esophageal squamous cell carcinoma.
    Liang S; Li C; Gao Z; Li J; Zhao H; Yu J; Meng X
    Int Immunopharmacol; 2021 Jan; 90():107178. PubMed ID: 33218939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CT-based radiomics combined with hematologic parameters for survival prediction in locally advanced esophageal cancer patients receiving definitive chemoradiotherapy.
    Cui J; Zhang D; Gao Y; Duan J; Wang L; Li L; Yuan S
    Insights Imaging; 2024 Mar; 15(1):87. PubMed ID: 38523188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Nutrition-Related Factor-Based Risk Stratification for Exploring the Clinical Benefits in the Treatment of Patients With Locally Advanced Esophageal Squamous Cell Carcinoma Receiving Definitive Chemoradiotherapy: A Retrospective Cohort Study.
    Yu Y; Wu H; Qiu J; Ke D; Wu Y; Lin M; Liu T; Zheng Q; Zheng H; Yang J; Wang Z; Li H; Liu L; Yao Q; Li J; Cheng W; Chen X
    Front Nutr; 2022; 9():896847. PubMed ID: 35990358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a prognostic nomogram and risk stratification system for upper thoracic esophageal squamous cell carcinoma.
    Lin Y; Zheng B; Chen J; Huang Q; Ye Y; Yang Y; Chen Y; Chen B; You M; Wang Q; Xu Y
    Front Oncol; 2023; 13():1059539. PubMed ID: 37124485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and validation of nomogram based on lncRNA ZFAS1 for predicting survival in lymph node-negative esophageal squamous cell carcinoma patients.
    Shi H; Liu Z; Pei D; Jiang Y; Zhu H; Chen B
    Oncotarget; 2017 Aug; 8(35):59048-59057. PubMed ID: 28938617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term outcomes of multimodal therapy combining definitive chemoradiotherapy and salvage surgery for T4 esophageal squamous cell carcinoma.
    Sugawara K; Yagi K; Okumura Y; Nishida M; Aikou S; Yamashita H; Yamashita H; Seto Y
    Int J Clin Oncol; 2020 Apr; 25(4):552-560. PubMed ID: 31828451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and validation of a nomogram to predict overall survival of T1 esophageal squamous cell carcinoma patients with lymph node metastasis.
    Yu J; Hu W; Yao N; Sun M; Li X; Wang L; Yang Y; Li B
    Transl Oncol; 2021 Aug; 14(8):101127. PubMed ID: 34020370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and validation of a new clinical staging system to predict survival for esophageal squamous cell carcinoma patients: Application of the nomogram.
    Shao CY; Liu XL; Yao S; Li ZJ; Cong ZZ; Luo J; Dong GH; Yi J
    Eur J Surg Oncol; 2021 Jun; 47(6):1473-1480. PubMed ID: 33349524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive and prognostic markers from endoscopic ultrasound with biopsies during definitive chemoradiation therapy in esophageal squamous cell carcinoma.
    Du Q; Wu X; Zhang K; Cao F; Zhao G; Wei X; Guo Z; Li Y; Dong J; Zhang T; Zhang W; Wang P; Chen X; Pang Q
    BMC Cancer; 2023 Jul; 23(1):681. PubMed ID: 37474893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic nomogram integrated systemic inflammation score for patients with esophageal squamous cell carcinoma undergoing radical esophagectomy.
    Shao Y; Ning Z; Chen J; Geng Y; Gu W; Huang J; Pei H; Shen Y; Jiang J
    Sci Rep; 2015 Dec; 5():18811. PubMed ID: 26689680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and validation of a radiomics-based model to predict local progression-free survival after chemo-radiotherapy in patients with esophageal squamous cell cancer.
    Luo HS; Chen YY; Huang WZ; Wu SX; Huang SF; Xu HY; Xue RL; Du ZS; Li XY; Lin LX; Huang HC
    Radiat Oncol; 2021 Oct; 16(1):201. PubMed ID: 34641928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A nomogram based on pretreatment CT radiomics features for predicting complete response to chemoradiotherapy in patients with esophageal squamous cell cancer.
    Luo HS; Huang SF; Xu HY; Li XY; Wu SX; Wu DH
    Radiat Oncol; 2020 Oct; 15(1):249. PubMed ID: 33121507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Survival Prediction Nomogram for Esophageal Squamous Cell Carcinoma Treated with Neoadjuvant Chemoradiotherapy Followed by Surgery.
    Ding T; Liu C; Huang B; Chu L; Wei L; Lin Y; Luo Y; Zhang B; Hong C; Xu Y; Peng Y
    Cancer Manag Res; 2021; 13():7771-7782. PubMed ID: 34675672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of Pathologic Response to Neoadjuvant Chemoradiotherapy in Patients with Esophageal Squamous Cell Carcinoma Incorporating Hematological Biomarkers.
    Wu Y; Chen J; Zhao L; Li Q; Zhu J; Yang H; Guo S; Xi M
    Cancer Res Treat; 2021 Jan; 53(1):172-183. PubMed ID: 32898941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Novel Model Combining Tumor Length, Tumor Thickness, TNM_Stage, Nutritional Index, and Inflammatory Index Might Be Superior to the 8th TNM Staging Criteria in Predicting the Prognosis of Esophageal Squamous Cell Carcinoma Patients Treated With Definitive Chemoradiotherapy.
    Chen X; Yu Y; Wu H; Qiu J; Ke D; Wu Y; Lin M; Liu T; Zheng Q; Zheng H; Yang J; Wang Z; Li H; Liu L; Yao Q; Li J; Cheng W
    Front Oncol; 2022; 12():896788. PubMed ID: 35719969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neutrophil-to-lymphocyte ratio as a prognostic biomarker for patients with locally advanced esophageal squamous cell carcinoma treated with definitive chemoradiotherapy.
    Zhou XL; Li YQ; Zhu WG; Yu CH; Song YQ; Wang WW; He DC; Tao GZ; Tong YS
    Sci Rep; 2017 Feb; 7():42581. PubMed ID: 28195186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival and prognostic factors in patients with synchronous multiple primary esophageal squamous cell carcinoma receiving definitive radiotherapy: A propensity score-matched analysis.
    Wang W; Liu X; Dang J; Li G
    Front Oncol; 2023; 13():1132423. PubMed ID: 37035207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.